Presentations
= Full text available
- Appropriateness of healthcare decisionmaking: what multicriteria decision analysis (MCDA) can bring?
Goetghebeur M
Conference on the Dimensions of Appropriateness in Health Care. November 11, 2011, Milan, Italy. - Validating a multi-criteria decision analysis (MCDA) framework for health care decision making.
Lieferink M, van Til J, Groothuis-Oudshoorn,K, Goetghebeur M, Dolan J
International Society for Pharmacoeconomics and Outcomes Research 14th Annual European Congress, November 5-8, 2011, Madrid, Spain.
- Stroke prevention in patients with atrial fibrillation: inappropriate anticoagulation and poor INR control.
Evers T, O’Neil WM, Ogilvie IM, Welner SA, Lip GYH
International Society for Pharmacoeconomics and Outcomes Research 14th Annual European Congress, November 5-8, 2011, Madrid, Spain. - A common road map for rational clinical and policy decisionmaking: application of the MCDA-based EVIDEM framework to growth hormone use in patients with Prader-Willi syndrome.
Tony M, Goetghebeur MM, Khoury H, Wagner M, Deal CL, Battista R
International Society for Pharmacoeconomics and Outcomes Research 14th Annual European Congress, November 5-8, 2011, Madrid, Spain. - Multicriteria decision analysis (MCDA): a common road map from drug development to regulatory and reimbursement decisions?
Moderator: Ron Goeree MA
Panelists: Bruno Flamion MD, PhD, Carole Longson PhD, Mireille Goetghebeur PhD
International Society for Pharmacoeconomics and Outcomes Research 14th Annual European Congress, November 5-8, 2011, Madrid, Spain. - Lessons learned from a Multicriteria Decision Analysis Framework
Goetghebeur MM
Institute of Medicine, Workshop on Country Level Decisionmaking for Chronic Diseases, July 19-21, 2011, Washington, DC, USA
- HPV vaccine acceptability across the globe
Weiss T, Nwankwo C, Wagner M, Singhal P, Rosenthal S, Zimet G
27th International Papillomavirus Conference and Clinical Workshop, September 17-22, 2011, Berlin, Germany
- Canadian Healthcare: Delivery & Opportunities for Collaboration
Welner S, Smofsky A, Hobson C
Care Continuum Alliance: The Forum 11- International Symposium
September 6, 2011, San Francisco, California, USA - From efficacy to equity in rare disorders: clinical and policy decisionmaking on growth hormone for patients with Prader-Willi syndrome using the EVIDEM HTA web mode.
Tony M, Goetghebeur MM, Khoury H, Wagner M, Deal CL, Battista R
Health Technology Assessment International, Annual meeting 2011, June 27-29, 2011, Rio de Janeiro, Brazil - From efficacy to equity: review of decision criteria used in resource allocation and healthcare decisionmaking
Goetghebeur MM, Guindo LA, Wagner M, Baltussen R, Rindress D, Van Til J, Kind P
Health Technology Assessment International, Annual meeting 2011, June 27-29, 2011, Rio de Janeiro, Brazil - Burden of community acquired and nosocomial rotavirus gastroenteritis in the pediatric population of western Europe
Ogilvie I, Khoury H, Goetghebeur M, El Khoury A, Giaquinto C
European Society for Paediatric Infectious Diseases, 29th Annual meeting, June 7-12, 2011, the Hague, The Netherlands - Which criteria are used in healthcare decisionmaking and priority setting? a literature review for an international survey of decisionmakers
Guindo LA, Wagner M, Baltussen R, Rindress D, Van Til J, Kind P, Goetghebeur MM
International Society for Pharmacoeconomics and Outcome Research, Annual international meeting, May 21-25, 2011, Baltimore, Maryland, USA -
Comparative effectiveness of banked donor milk for premature infants: efficiency of a milk bank model integrated in a blood bank setting
Richer E, Dourdin N, Goetghebeur MM
International Society for Pharmacoeconomics and Outcome Research, Annual international meeting, May 21-25, 2011, Baltimore, Maryland, USA - Systematic review of guidelines for health economic evaluations
Melnyk P, Wagner M, Dourdin N, Rindress D
International Society for Pharmacoeconomics and Outcome Research, Annual international meeting, May 21-25, 2011, Baltimore, Maryland, USA -
Establishing the Value of Innovative Medicines While Dealing with Uncertainty Using Multi-Criteria Decision Analysis (MCDA)
Goetghebeur MM
CAPT 2011 Annual Conference, April 17-19, 2011, Ottawa, Ontario, Canada -
Decisionmaking for rare diseases: developing evidence-based clinical practice guidelines for growth hormone therapy in Prader-Willi syndrome using the EVIDEM framework
Tony M, Goetghebeur MM, Khoury H, Wagner M, Battista R, Deal CL
CAPT 2011 Annual Conference, April 17-19, 2011, Ottawa, Ontario, Canada -
Systematic review to assess the quality of published health economic evaluations
Dourdin N, Wagner M, Melnyk P and Rindress D
CAPT 2011 Annual Conference, April 17-19, 2011, Ottawa, Ontario, Canada -
Implementing a milk bank in the province of Quebec: from evidence to practice
Dourdin N, Richer E, Goetghebeur MM
Canadian Agency for Drugs and Technologies in Health, 2011 Annual meeting, April 3-5, 2011, Vancouver, British Colombia, Canada - Adapting the EVIDEM framework to support the development of evidence-based clinical practice guidelines: A case study of growth hormone therapy in Prader-Willi syndrome
Tony M, Goetghebeur MM, Wagner M, Khoury H, Battista R, Deal CL
Canadian Agency for Drugs and Technologies in Health, 2011 Annual meeting, April 3-5, 2011, Vancouver, British Colombia, Canada -
Symposium – panel
How Can Decision Makers Consider Other Factors in Decision Making: Multi-Criteria to Maximize Opportunities to Bring Evidence Into Practice
Panelists: Mireille Goetghebeur, Ron Goeree, Janet Martin, Paule Poulin
Moderator: Tammy Clifford
Canadian Agency for Drugs and Technologies in Health, 2011 Annual meeting, April 3-5, 2011, Vancouver, British Colombia, Canada - Bridging multicriteria decision analysis (MCDA) with health technology assessment (HTA) for policy and clinical decisionmaking: case studies in Canada and South Africa
Goetghebeur MM, Deal C, Miot J, Tony M, Wagner M, Khoury H, Rindress R, Oh P
SMDM 2010 Annual Meeting, 24-27 Oct 2010, Toronto, ON, Canada - Measuring and benchmarking outcomes in healthy workplace wellness programs
Melnyk P, Smofsky A
Health Work and Wellness Conference, 29 Sep- 2 Oct 2010, Vancouver, BC, Canada - Burden of rotavirus gastroenteritis in the pediatric population of the Middle East and North Africa
Ogilvie I, Khoury H, El-Khoury A, Duan Y, Goetghebeur M
26th International Pediatric Association, Congress of Pediatrics 2010 (IPA) 4-9 Aug 2010, Johannesburg, South Africa - Burden of rotavirus gastroenteritis in the pediatric population of the Middle East and North Africa
Ogilvie I, Khoury H, El-Khoury A, Duan Y, Goetghebeur M
9th International Rotavirus Symposium 2010, South Africa, 2-3 Aug 2010, Johannesburg, South Africa - Multicriteria Decision Analysis (MCDA) for drug coverage decision by a Public Health Plan: case study of tramadol for chronic non-cancer pain (CNCP) in Canada
Tony M, Goetghebeur MM, Wagner M, Khoury H, Rindress D, Oh P
15th Annual ISPOR International Meeting, 15-19 May 2010, Altanta, GA, USA - Burden of rotavirus gastroenteritis in the pediatric population of the Middle East and North Africa
Ogilvie I, Khoury H, El-Khoury A, Duan Y, Goetghebeur M
European Society for Pediatric Infectious Diseases, 4-8 May 2010, Nice, France - Multicriteria decision analyses for healthcare decisionmaking: feedback from the field on the value of the EVIDEM framework in Canadian and South African settings
Goetghebeur MG, Miot J, Tony M, Wagner M, Khoury H, Rindress D, Oh P
The International Society for Priorities in Health Care, 23-25 April 2010, Boston, MA, USA - Bridging health technology assessment with multicriteria decision analyses: field testing of the EVIDEM framework to support coverage decision for tramadol by a public health plan in Canada
Tony M, Goetghebeur MG, Wagner M, Khoury H, Rindress D, Oh P
CADTH 2010 Symposium, 18-20 April 2010, Halifax, NS, Canada - Bridging Health Technology Assessment (HTA) with Multi Criteria Decision Analysis (MCDA), values and ethics for complex decisions: case study of growth hormone for Turner Syndrome
Goetghebeur MM, Wagner M, Khoury H, Rindress D, Grégoire JP, Deal C
ISPOR 12th Annual European Congress, 24-27 October 2009, Paris, France - Field testing of a Multicriteria Decision Analyses (MCDA) framework for coverage of a diagnostic test for cervical cancer in South Africa
Miot J, Wagner M, Khoury H, Anderson AN, Rindress D, Goetghebeur MM
ISPOR 12th Annual European Congress, 24-27 October 2009, Paris, France - Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions
Ogilvie I, El Khoury A, Cui A, Dasbach E, Grabenstein JD, Goetghebeur M
ISPOR 14th Annual Meeting, 16-20 May, 2009, Orlando, Florida, USA - Growth hormone for treating Turner syndrome in Canada: structuring evidence into the EVIDEM multicriteria decision analysis framework to support decisionmaking
Goetghebeur MM, Khoury H, Wagner M, Rindress D, Grégoire JP, Deal C
CAPT 2009 Annual Conference, 19-21 April, 2009, Montreal, Quebec, Canada - Field application of the EVIDEM multicriteria decision framework to support coverage decisions for a screening test
Goetghebeur MM, Miot J, Wagner W, A Nixon Anderson, Khoury H, Rindress D
CADTH 20th Anniversary 2009 Symposium, 5-7 April 2009, Ottawa, Ontario, Canada - Sub-optimal oral anticoagulant treatment in patients with atrial fibrillation and the effect of study setting on clinical event rates: a systematic review
Ogilvie IM, Newton N, Welner SA, Lip GYH
American College of Cardiology and i2 Summit 58th Annual Scientific Session, 29-31 March 2009, Orlando, Florida, USA - Evidence and Value: Impact on DEcisionMaking (EVIDEM)—a practical framework applying mutlicriteria decision analysis (MCDA) to support healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
CADTH 2008 Invitational Symposium, 28-29 April 2008, Edmonton, Alberta, Canada - Cost-effectiveness of atorvastatin 10 mg daily in the primary prevention of major cardiovascular events in patients with type 2 diabetes in Canada
Khoury H, Wagner M, Merikle E, Johnson SJ, Roberts C
9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 30 Apr–2 May 2008, Baltimore, Maryland, USA - Evidence and Value: Impact on DEcisionMaking—the EVIDEM framework and potential applications
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
ISPOR 13th Annual International Meeting, 3-7 May 2008, Toronto, Ontario, Canada - Transparent and quantifiable approaches to healthcare decisionmaking: challenges and opportunities for Multi Criteria Decision Analysis (MCDA)
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
ISPOR 13th Annual International Meeting, 3-7 May 2008, Toronto, Ontario, Canada - Costs related to adverse events in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors in Canada
Newton N, Goetghebeur MM, El Ouagari K
ISPOR 13th Annual International Meeting, 3-7 May 2008,Toronto, Ontario, Canada - Concordance with compression therapy in the treatment of venous leg ulcers
Machado F, Kommala D, Dourdin N, Welner S, Choe Y
European Wound Management Association (EWMA) Conference, 14-16 May 2008, Lisbon, Portugal. - Evidence and Value: Impact on DEcisionMaking (EVIDEM)—applying Multi-Criteria Decision Analysis (MCDA) to support healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
5th Annual Meeting HTAi 2008, 6-9 July 2008, Montreal, Quebec, Canada - Multi Criteria Decision Analysis (MCDA) in healthcare decisionmaking: towards transparent and quantifiable approaches
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
5th Annual Meeting HTAi 2008,6-9 July 2008, Montreal, Quebec, Canada - How do Evidence and Value Impact DEcisionMaking? EVIDEM – a practical framework applying Multi-Criteria Decision Analysis (MCDA) to structure and facilitate healthcare decisionmaking
Goetghebeur MM, Wagner M, Khoury H, Levitt R, Erickson LJ, Rindress D
9th World Conference on Clinical Pharmacology and Therapeutics Annual Meeting, 27 July-1 Aug, 2008, Quebec City, Canada - Cost-effectiveness of 80 mg versus 10 mg atorvastatin in Canada based on results of the TNT study
Wagner M, Merikle E, Goetghebeur M, Pandya A, Chu P, Taylor DCA
4th Canadian Therapeutics Congress, 27-30 May 2007, Halifax, NS, Canada - Economic evaluation of intensive atorvastatin compared to standard simvastatin treatment in Canada based on the IDEAL trial
Wagner M, Lindgren P, Merikle E , Goetghebeur M, Jönsson B & the IDEAL Steering Committee Investigators.
4th Canadian Therapeutics Congress, 27-30 May 2007, Halifax, NS, Canada - Methicillin-resistant Staphylococcus aureus: a public health issue with economic consequences
Goetghebeur M, Landry P, Han D, Vicente C
3rd annual conference of the Canadian Therapeutics Congress, 10-13 May 2006, Toronto, Ontario. Canada - Real world issues facing outcomes data collection and analysis – case studies
Rindress D
Disease Management Leadership Forum, 16 October 2005, San Diego, California, USA - Trends
in pharmaceutical spending growth in the United States, 1998-2002
Roberts WM, Rindress D
ISPOR 10th Annual International Meeting, 15-18 May 2005, Washington, DC, USA
- Economic
impact of reduced incidence of diabetes in patients with left ventricular
dysfunction treated with enalapril
McLachlin DT, Rindress D, Desjardins B, Tardif J-C
2005 Canadian Association for Population Therapeutics Conference, 17-19 April 2005, Vancouver, BC, Canada
- Economic
impact of reduced incidence of atrial fibrillation in patients with left
ventricular dysfunction treated with enalapril
Wagner M, McLachlin DT, Rindress D, Desjardins B, Ducharme A, Tardif J-C
54th Annual Scientific Session of the American College of Cardiology, 6-9 March 2005, Orlando, FL, USA
- Global Economic Dossiers: speaking with one voice globally
Rindress D
Drug Information Association workshop on Medical/Technical Writing and Document Preparation for the Pharmaceutical Industry, October 2002, Baltimore, MD, USA - Application
of health economics in the Canadian pharmaceutical industry
Hirji Z, Rindress DE, Welner SA
ISPOR 6th Annual International Meeting , 20-23 May 2001, Washington, DC, USA
- Begin with the end in mind: issues in planning pharmacoeconomic
research for more effective communication
Rindress D
ISPOR 4th Annual International Meeting 23-26 May 1999, Crystal City, VA, USA, Value in Health 1999;2(3):227 - Effectively reporting pharmacoeconomic data: clarity and content
Rindress D, Welner S, Goetghebeur M
2nd Annual Meeting of the Association for Pharmacoeconomics and Outcomes Research, 23-26 April 1997,
Philadelphia, PA, USA - Meeting the emerging standards for reporting pharmacoeconomic
data
Rindress D, Welner S, Goetghebeur M
Drug Information Association workshop on Medical/Technical Writing and Document Preparation for the Pharmaceutical Industry, 3-4 April 1997, Baltimore, MD, USA - Cost effectiveness of paclitaxel in advanced ovarian cancer
Rivière M, Rindress D, Souêtre E
1st Annual Meeting of the Association for Pharmacoeconomics and Outcomes Research, 12-15 May 1996, Philadelphia, PA, USA, Clinical Therapeutics 1996;18(Suppl.A):24.